Specific binding proteins for treating canine allergy

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/42 (2006.01) A61K 39/44 (2006.01)

Patent

CA 2329148

Disclosed are binding proteins that specifically bind to an isolated and purified peptide comprising a leucine positioned two peptide bonds away from a tyrosine-arginine pair. Other binding proteins of the invention include those that specifically bind to an isolated and purified peptide with the sequence cysteine-blank-blank-proline-histidine-blank-blank-blank-cysteine (SEQ ID NO:6) or cysteine-blank-proline-histidine-blank-proline-blank-blank-cysteine (SEQ ID NO:9).

Cette invention concerne des protéines de liaison qui se lient spécifiquement l un peptide isolé et purifié comprenant une leucine positionnées entre duc liaisons peptidiques à l'écart d'une paire tyrosine-arginine. Parmi les autres protéines de liaison selon l'invention figure celles qui se lient spécifiquement à une peptide isolée et purifiée avec la séquence cystéine-blanc-blanc-proline-histidine-blanc-blanc-blanc-cystéine (SEQ ID NO:6) ou cystéine-blanc-proline-histidine-blanc-proline-blanc-blanc-cystéine (SEQ ID NO:9).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Specific binding proteins for treating canine allergy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Specific binding proteins for treating canine allergy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific binding proteins for treating canine allergy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1990548

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.